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Clinical Relevancy Statement {#jpen1663-sec-0050}
============================

Our findings may indicate that septic and non‐septic patients have different nutritional needs in the first week of intensive care unit (ICU) admission. Moreover, divergent time‐dependent associations of protein intake were observed. However, current guidelines suggest similar nutrition needs during ICU admission, neglecting subgroups and time‐dependent effects. This hypothesis‐generating study underlines the need for large prospective trials to develop more tailor‐based approaches for nutrition in critically ill patients.

Introduction {#jpen1663-sec-0060}
============

Sepsis is a syndrome defined by life‐threatening organ dysfunction because of a dysregulated host response to infection.[1](#jpen1663-bib-0001){ref-type="ref"} Sepsis accounts for 10% of all intensive care unit (ICU) admissions in the Netherlands and results in a marked in‐hospital mortality of 28% compared with 13% in general non‐septic ICU patients.[2](#jpen1663-bib-0002){ref-type="ref"} Optimal nutrition support in critically ill patients is associated with lower mortality and long‐term outcome[3](#jpen1663-bib-0003){ref-type="ref"}; however, evidence in septic patients is scarce.[4](#jpen1663-bib-0004){ref-type="ref"}, [5](#jpen1663-bib-0005){ref-type="ref"} Although septic patients are considered a subgroup of critically ill patients and guidelines suggest similar nutrition needs, they may not experience the same level of inflammation, severity of illness, and metabolic changes (ie, changes in energy expenditure and protein catabolism) as compared with non‐septic patients.[6](#jpen1663-bib-0006){ref-type="ref"}

Protein Intake {#jpen1663-sec-0070}
--------------

Protein intake is essential to prevent muscle loss; however, muscle loss cannot be completely counteracted by nutrition support.[7](#jpen1663-bib-0007){ref-type="ref"} It has been suggested that protein intake may be more important than energy intake.[8](#jpen1663-bib-0008){ref-type="ref"} Most observational studies found that higher protein intake was associated with better outcomes in general ICU and septic patients.[9](#jpen1663-bib-0009){ref-type="ref"}, [10](#jpen1663-bib-0010){ref-type="ref"}, [11](#jpen1663-bib-0011){ref-type="ref"}, [12](#jpen1663-bib-0012){ref-type="ref"} However, this is not supported by few randomized controlled trials (RCTs) that have been performed in general ICU patients[13](#jpen1663-bib-0013){ref-type="ref"}, [14](#jpen1663-bib-0014){ref-type="ref"}, [15](#jpen1663-bib-0015){ref-type="ref"} and other evidence from septic patients.[16](#jpen1663-bib-0016){ref-type="ref"}, [17](#jpen1663-bib-0017){ref-type="ref"} Presumably, timing of nutrition interventions[18](#jpen1663-bib-0018){ref-type="ref"} might play an important role, and especially early (≤3 days) high protein intake may relate to negative effects.[19](#jpen1663-bib-0019){ref-type="ref"} Suggestions have been made that early protein intake inhibits autophagy.[20](#jpen1663-bib-0020){ref-type="ref"} Autophagy is essential to clear cell debris and intracellular bacteria in order to provide metabolic precursors.[21](#jpen1663-bib-0021){ref-type="ref"} Moreover, it has been related to cell survival and adverse outcomes.[22](#jpen1663-bib-0022){ref-type="ref"}

However, the interplay of nutrition, catabolism, inflammation, and autophagy is not well understood. Furthermore, the clinical implications and the role of autophagy preservation by adjustment of protein provision in severely catabolic ICU patients remains debated.[23](#jpen1663-bib-0023){ref-type="ref"}

Energy Provision {#jpen1663-sec-0080}
----------------

For energy intake, recent RCTs do not report survival benefit of early provision of approximately 100% of energy expenditure compared with lower energy intakes.[14](#jpen1663-bib-0014){ref-type="ref"}, [24](#jpen1663-bib-0024){ref-type="ref"}, [25](#jpen1663-bib-0025){ref-type="ref"} Furthermore, overfeeding (\>110%) has been associated with increased morbidity and mortality.[17](#jpen1663-bib-0017){ref-type="ref"}, [26](#jpen1663-bib-0026){ref-type="ref"} Most observational studies have reported the lowest mortality rate associations with energy intakes of 70%--90% of calculated or measured energy expenditure.[17](#jpen1663-bib-0017){ref-type="ref"}, [27](#jpen1663-bib-0027){ref-type="ref"}

Most of the aforementioned studies included general critically ill patients, and percentages of patients with sepsis are frequently unknown or relatively low. Subgroup analyses for septic patients were not performed. Therefore, the optimal amount and timing of nutrition intake in septic patients remains unknown. Our primary aim was to evaluate the effects of protein and energy intake and the timing of these interventions in critically ill septic patients during the first week of ICU admission on 6‐month mortality and to compare findings with non‐septic patients. We expected to find a stronger association of early high protein intake and higher 6‐month mortality in septic patients than in non‐septic patients, speculating that early high protein intake suppresses autophagy, which could play a more prominent role in septic patients.

Methods {#jpen1663-sec-0090}
=======

Study Description {#jpen1663-sec-0100}
-----------------

We performed a retrospective observational study among all consecutive, critically ill, mechanically ventilated patients in a mixed medical‐surgical ICU in a tertiary university‐affiliated teaching hospital between January 1, 2011, and April 1, 2016. Sepsis was defined as a suspected or proven infection within the first 24 hours of ICU admission, in combination with a Sequential Organ Failure Assessment (SOFA) score at admission of ≥2, concordant with the new sepsis‐3 definitions.[1](#jpen1663-bib-0001){ref-type="ref"}, [28](#jpen1663-bib-0028){ref-type="ref"} Outcomes of patients with and without sepsis were compared.

Patient Population {#jpen1663-sec-0110}
------------------

Patients were eligible for analysis if they were \>18 years old and received invasive mechanical ventilation for ≥7 days, commenced within 48 hours after ICU admission. Patients were excluded from analysis when no nutrition data were available, when their condition affected their nutrition demand (ie, pregnancy, preexistent neuromuscular diseases, chronic hemodialysis and \[protein\] malabsorption syndromes), or when they were on noninvasive or chronic home ventilation. If patients were readmitted to the ICU within 6 months, only data of the first admission were analyzed.

Baseline characteristics such as age, gender, admission type and diagnosis, baseline blood tests, SOFA score,[28](#jpen1663-bib-0028){ref-type="ref"} Acute Physiology and Chronic Health Evaluation II score,[29](#jpen1663-bib-0029){ref-type="ref"} Charlson Comorbidity Index,[30](#jpen1663-bib-0030){ref-type="ref"} Nutrition Risk in Critically Ill Patients score,[31](#jpen1663-bib-0031){ref-type="ref"} need for vasopressor agents, and presence of shock were used to assess baseline differences.

Subgroup Analyses {#jpen1663-sec-0120}
-----------------

Predefined subgroup analyses were performed addressing protein and energy intake in the first 7 days of ICU admission. Both were divided into 3 groups: protein intake \<0.8 g/kg/d, 0.8--1.2 g/kg/d, and \>1.2 g/kg/d[17](#jpen1663-bib-0017){ref-type="ref"} and energy intake \<80%, 80%--110%, and \>110% of energy target.[17](#jpen1663-bib-0017){ref-type="ref"}, [26](#jpen1663-bib-0026){ref-type="ref"}, [32](#jpen1663-bib-0032){ref-type="ref"} Energy intake, including energy from trisodium citrate, propofol, and glucose infusions, was monitored during complete ICU stay according to published methods.[33](#jpen1663-bib-0033){ref-type="ref"}, [34](#jpen1663-bib-0034){ref-type="ref"}, [35](#jpen1663-bib-0035){ref-type="ref"}

Target protein prescriptions were 1.5 g/kg/d for patients with body mass index (BMI) \<27 kg/m^2^; in case of BMI 27--30, weight was corrected to BMI 27. In case of BMI \>30, ideal weight was used and target protein administration was set to 2.0 g/kg/d (BMI 30--40) or 2.5 g/kg/d (BMI \>40).[5](#jpen1663-bib-0005){ref-type="ref"} Energy targets were calculated by our computerized nutrition protocol based on the Food and Agricultural Organization and World Health Organization (FAO/WHO) formula.[36](#jpen1663-bib-0036){ref-type="ref"} In this study, 20% was added to resting energy expenditure to correct for disease activity.[37](#jpen1663-bib-0037){ref-type="ref"} Additionally, energy targets were calculated using the ventilator‐derived carbon dioxide output (VCO~2~; L/min) using VCO~2~ × 8.19.[38](#jpen1663-bib-0038){ref-type="ref"}

Outcome {#jpen1663-sec-0130}
-------

Primary outcome was 6‐month mortality. Dates of death were collected from the municipal administration on October 1, 2016. Secondary outcomes were ICU and in‐hospital mortality, length of stay (LOS), 6‐month all‐cause hospital readmission, ventilator‐free days, and presence of acute kidney injury according Risk, Injury, Failure, Loss of kidney function, and End‐stage kidney disease criteria.[39](#jpen1663-bib-0039){ref-type="ref"}

Data Collection and Protection {#jpen1663-sec-0140}
------------------------------

Data were automatically extracted using SAS Enterprise Guide queries from Metavision (Patient Data Management System, iMDsoft MetaVision, Tel Aviv, Israel) and other hospital electronic patient records. Verification was performed manually. Collected data were deidentified and stored on a secure hospital computer. There were no identifiable paper documents.

Ethics Approval {#jpen1663-sec-0150}
---------------

The Gelderse Vallei Hospital Institutional Review Board approved the study and waived informed consent for reasons of the retrospective design and anonymization of patient identifiers before analysis.

Statistical Analysis {#jpen1663-sec-0160}
--------------------

Continuous data are reported as mean and standard deviation (SD) or as median and interquartile range \[IQR\], depending on data distribution. Differences in continuous variables were analyzed using independent *t*‐tests or Mann‐Whitney *U* tests where appropriate. Categorical variables are presented as frequencies and percentages. Differences were analyzed using χ^2^ or Fischer\'s exact tests. Six‐month mortality was assessed by χ^2^ test, Kaplan‐Meier survival functions, and Cox proportional hazards models. All baseline and nutrition variables (Tables [1](#jpen1663-tbl-0001){ref-type="table"} and [2](#jpen1663-tbl-0002){ref-type="table"}) were included in unadjusted Cox regression analysis. For the primary outcome measure, when univariate analysis revealed *P* \< 0.10, multivariate analysis was performed. Multicollinearity of variables included into multivariate analyses was assessed by calculation of the variance inflation factor (VIF). We considered a VIF \>2 as an indicator of relevant collinearity. Results of multivariate Cox regression will only be included in supplementary material for illustrative reasons because of small sample sizes (Tables S1--S3). Leave‐1‐out cross‐validation of the univariate Cox regression was performed for admission year. Analyses were performed using IBM SPSS Statistics for Windows and for Macintosh, version 23.0 (IBM Corporation, released 2013, Armonk, New York, USA). A *P* value \< 0.05 was considered statistically significant.

###### 

Baseline Characteristics

  Variable                                                                            Total, n = 423        Sepsis, n = 297       No Sepsis, n = 126    *P* [a](#jpen1663-tbl1-note-0002){ref-type="fn"}
  ----------------------------------------------------------------------------------- --------------------- --------------------- --------------------- -----------------------------------------------------
  Gender, male, n (%)                                                                 253 (59.8)            166 (55.9)            87 (69.0)             0.013[e](#jpen1663-tbl1-note-0006){ref-type="fn"}
  Age, years, median \[IQR\]                                                          71 \[62--77\]         71 \[61--77\]         71 \[63.8--77.3\]     0.538
  BMI, kg/m^2^, median \[IQR\]                                                        26.6 \[23.6--30.5\]   26.6 \[23.5--29.9\]   26.7 \[24.4--30.7\]   0.278
  \<25, n (%)                                                                         156 (36.9)            111 (37.4)            45 (35.7)             
  25--35, n (%)                                                                       225 (53.2)            159 (53.5)            66 (52.4)             
  \>35, n (%)                                                                         42 (9.9)              27 (9.1)              15 (11.9)             
  APACHE II score on admission, mean (SD)                                             23.4 (7.0)            23.1 (5.72)           24.2 (7.3)            0.143
  SOFA score on admission, mean (SD)                                                  8.1 (3.0)             8.1 (3.1)             8.1 (2.9)             0.858
  SOFA \<2, n (%)                                                                     2 (0.5)               0                     2 (1.6)               
  SOFA ≥2, n (%)                                                                      421 (99.5)            297 (100)             124 (98.4)            
  Charlson Comorbidity Index, mean (SD)[b](#jpen1663-tbl1-note-0003){ref-type="fn"}   4.2 (2.4)             4.2 (2.5)             4.1 (2.1)             0.914
  Nutric score, mean (SD)                                                             5.1 (1.8)             5.1 (1.8)             5.2 (1.7)             0.408
  Nutric score 0--4, n (%)                                                            154 (36.4)            113 (38.0)            41 (32.5)             
  Nutric score ≥5, n (%)                                                              269 (63.6)            184 (62.0)            85 (67.5)             
  Baseline creatinine, μmol/L, median \[IQR\]                                         101 \[73--147\]       101 \[72--164\]       99 \[74--124\]        0.171
  Admission type                                                                                                                                        0.067
  Medical, n (%)                                                                      282 (66.7)            208 (70.0)            74 (58.7)             
  Elective surgical, n (%)                                                            61 (14.4)             37 (12.5)             24 (19.0)             
  Emergency surgery, n (%)                                                            80 (18.9)             52 (17.5)             28 (22.2)             
  Positive SIRS criteria on admission[c](#jpen1663-tbl1-note-0004){ref-type="fn"}                                                                       \<0.001[e](#jpen1663-tbl1-note-0006){ref-type="fn"}
  \<2, n (%)                                                                          44 (10.4)             21 (7.1)              23 (18.3)             
  ≥2, n (%)                                                                           339 (80.1)            255 (85.9)            84 (66.7)             
  Missing data, n (%)                                                                 40 (9.5)              21 (7.1)              19 (15.1)             
  Vasopressors first 24 hours of ICU admission                                                                                                          0.327
  Yes, n (%)                                                                          258 (61)              186 (62.6)            72 (57.1)             
  No, n (%)                                                                           165 (39)              111 (37.4)            54 (42.8)             
  Shock first 24 hours of ICU admission[d](#jpen1663-tbl1-note-0005){ref-type="fn"}                                                                     0.338
  Yes, n (%)                                                                          194 (45.9)            141 (47.5)            53 (42.1)             
  No, n (%)                                                                           229 (54.1)            156 (52.5)            73 (57.9)             
  Site of initial infection                                                           NA                                          NA                    NA
  Lung, n (%)                                                                                               153 (51.5)                                  
  Abdomen, n (%)                                                                                            98 (33.0)                                   
  Urinary tract, n (%)                                                                                      19 (6.4)                                    
  Neurologic site, n (%)                                                                                    7 (2.4)                                     
  Primary bloodstream, n (%)                                                                                2 (0.7)                                     
  Skin and soft tissue                                                                                      9 (3.0)                                     
  Other                                                                                                     9 (3.0)                                     

APACHE II, Acute Physiology and Chronic Health Evaluation; BMI, body mass index; ICU, intensive care unit; IQR, interquartile range (1st--3rd quartile); NA, not applicable; NUTRIC, Nutritional Risk in Critically Ill; SIRS, systemic inflammatory response syndrome; SOFA, Sequential Organ Failure Assessment; SD, standard deviation.

Comparison of sepsis and non‐sepsis group, calculated by Pearson\'s χ^2^ test, independent *t*‐test or Mann‐Whitney *U* test as appropriate.

Charlson Comorbidity Index predicts 10‐year mortality from 22 comorbid conditions.

SIRS criteria: leucocytes \<4 × 10^9^/L or \>12 × 10^9^/L, respiratory rate \>20 breaths/min, heart rate \>90 beats/min, temperature \<36.0°C or \>38.3°C.

Shock was defined as the need for vasopressors the first 24 hours after ICU admission and lactate \>2 mmol/L.

*P* \< 0.05.

John Wiley & Sons, Ltd.

###### 

Feeding Parameters

  Variable                                                                                                                                                Total Population, n = 423   Sepsis, n = 297       No Sepsis, n = 126    *P* [a](#jpen1663-tbl2-note-0002){ref-type="fn"}
  ------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------- --------------------- --------------------- ---------------------------------------------------
  Time to start feeding, hours, median \[IQR\]                                                                                                            6.0 \[3.2--15.5\]           6.1 \[3.3--14.5\]     5.7 \[2.9--17.2\]     0.844
  Patients parenterally fed, days 1--3, n (%)                                                                                                             40 (9.5)                    33 (11.1)             7 (5.6)               0.074
  Patients parenterally fed, days 4--7, n (%)                                                                                                             39 (9.2)                    29 (9.8)              10 (7.9)              0.552
  Protein intake                                                                                                                                                                                                                  
  Daily protein target, g, mean (SD)                                                                                                                      115.5 (20.9)                113.8 (20.6)          119.3 (21.2)          0.013[e](#jpen1663-tbl2-note-0006){ref-type="fn"}
  Total protein intake 7 days, g, mean (SD)                                                                                                               522.19 (154.6)              517.5 (148.0)         532.8 (169.1)         0.352
  Protein intake days 1--3, g/kg/d, median \[IQR\]                                                                                                        0.72 \[0.42--0.97\]         0.75 \[0.44--0.99\]   0.59 \[0.34--0.91\]   0.010[e](#jpen1663-tbl2-note-0006){ref-type="fn"}
  \<0.8, n (%)                                                                                                                                            249 (58.9)                  166 (55.9)            83 (65.9)             
  0.8--1.2, n (%)                                                                                                                                         140 (33.1)                  103 (34.78)           37 (29.4)             
  \>1.2, n (%)                                                                                                                                            34 (8.0)                    28 (9.4)              6 (4.8)               
  Protein intake days 4--7, g/kg/d, mean (SD)                                                                                                             1.21 (0.30)                 1.21 (0.31)           1.21 (0.29)           0.976
  \<0.8, n (%)                                                                                                                                            35 (8.3)                    24 (8.1)              11 (8.7)              
  0.8--1.2, n (%)                                                                                                                                         161 (38.1)                  116 (39.1)            45 (35.7)             
  \>1.2, n (%)                                                                                                                                            227 (53.7)                  157 (52.9)            70 (55.6)             
  Energy intake                                                                                                                                                                                                                   
  Daily energy target in kcal[b](#jpen1663-tbl2-note-0003){ref-type="fn"}, mean (SD)                                                                      1704 (324)                  1694 (321)            1727 (331)            0.340
  Daily energy target in kcal, based on VCO~2~ [c](#jpen1663-tbl2-note-0004){ref-type="fn"}, mean (SD)                                                    1818 (366)                  1798 (376)            1863 (340)            0.234
  Total energy intake in kcal[d](#jpen1663-tbl2-note-0005){ref-type="fn"}, mean (SD)                                                                      9871 (2436)                 9877 (2419)           9857 (2486)           0.937
  Adequacy energy intake to target[b](#jpen1663-tbl2-note-0003){ref-type="fn"} ^,^ [d](#jpen1663-tbl2-note-0005){ref-type="fn"}, days 1--3, mean % (SD)   67.2 (28.6)                 69.4 (28.5)           62.1 (28.3)           0.016[e](#jpen1663-tbl2-note-0006){ref-type="fn"}
  \<80%, n (%)                                                                                                                                            268 (63.4)                  178 (59.9)            90 (71.4)             
  80%--110%, n (%)                                                                                                                                        130 (30.7)                  102 (34.3)            28 (22.2)             
  \>110%, n (%)                                                                                                                                           25 (5.9)                    17 (5.7)              8 (6.3)               
  Adequacy energy intake to target[b](#jpen1663-tbl2-note-0003){ref-type="fn"} ^,^ [d](#jpen1663-tbl2-note-0005){ref-type="fn"}, days 4--7, mean % (SD)   107 (25)                    107 (24)              107 (27)              0.760
  \<80%, n (%)                                                                                                                                            49 (11.6)                   34 (11.4)             15 (11.9)             
  80%--110%, n (%)                                                                                                                                        233 (55.1)                  158 (53.2)            75 (59.5)             
  \>110%, n (%)                                                                                                                                           141 (33.3)                  105 (35.4)            36 (28.6)             
  Non‐nutrition energy as % of total energy intake, median \[IQR\]                                                                                        7.7 \[3.6--15.7\]           7.6 \[4.0--15.9\]     8.5 \[3.0--15.0\]     0.886

IQR, interquartile range; SD, standard deviation.

Comparison of sepsis with non‐sepsis group, calculated with *t*‐test or Mann‐Whitney *U* test where appropriate.

Target based on World Health Organization formula for resting energy expenditure + 20%.

Target based on mean daily VCO~2~ × 8.19.

Nutritional + non‐nutritional energy.

*P* \< 0.05.

John Wiley & Sons, Ltd.

Results {#jpen1663-sec-0170}
=======

Patients {#jpen1663-sec-0180}
--------

During the study period, 3839 patients were admitted, of which 552 received invasive mechanical ventilation for ≥7 days, and of these, 423 were eligible for analysis (Figure S1). Sepsis was present in 297 patients (70.2%).

Baseline characteristics of the studied patients are depicted in Table [1](#jpen1663-tbl-0001){ref-type="table"}. Except for gender (sepsis group 56% men vs non‐sepsis 69% men, *P* = 0.013) and systemic inflammatory response syndrome, criteria baseline characteristics were comparable between groups. Regarding nutrition parameters (Table [2](#jpen1663-tbl-0002){ref-type="table"}), protein intake in the first 3 days after admission was significantly higher in the sepsis group (0.75 vs 0.59 g/kg/d, *P* = 0.010), despite significantly lower targets (114 vs 119 g/d, respectively, both 1.5 g/kg/d according to real or corrected body weight, *P* = 0.013). In addition, a higher percentage of energy target was achieved in septic patients in the first 3 days (69.4% vs 62.1%, *P* = 0.016), even though targets were comparable.

Primary Outcome {#jpen1663-sec-0190}
---------------

Six‐month mortality did not significantly differ between the sepsis and the non‐sepsis group (104 \[35.0%\] vs 49 \[38.9%\], respectively, *P* = 0.448).

Subgroup Analysis: Proteins {#jpen1663-sec-0200}
---------------------------

The effects of protein intake during the early (days 1--3) and later phase (days 4--7) of the first week were evaluated separately. In septic patients, no association was found between protein intake at days 1--3 and 6‐month mortality (Table [3](#jpen1663-tbl-0003){ref-type="table"}, Figure S2, Table S4). In the later phase, protein intake of 0.8--1.2 g/kg/d was significantly associated with a lower 6‐month mortality in univariate analysis (hazard ratio \[HR\]: 0.646, 95% confidence interval \[CI\]: 0.418--0.996, *P* = 0.048) compared with the high (\>1.2) protein intake subgroup (Table [3](#jpen1663-tbl-0003){ref-type="table"}, Figure S3).

###### 

Univariate Cox Proportional Hazards Model 6‐Month Mortality: Proteins‐Separated Early and Later Phase

  Protein Intake       Sepsis  No Sepsis                                                                                                                                           
  ------------------- -------- ----------- ----------- ------- ---------------- --------------------------------------------------- ---- ------ -------- ------- ----------------- ---------------------------------------------------
  Days 1--3, g/kg/d                                                                                                                                                                
  \<0.8                 166    0.47        Reference   83            0.41       Reference                                                                                          
  0.8--1.2              103    0.98        0.146       1.157    (0.764--1.752)  0.491                                                37  0.99   −0.116   0.891    (0.466--1.702)   0.726
  \>1.2                  28    1.34        0.367       1.444    (0.772--2.699)  0.250                                                6   1.25   1.362    3.902    (1.505--10.115)  0.005[a](#jpen1663-tbl3-note-0002){ref-type="fn"}
  Days 4--7, g/kg/d                                                                                                                                                                
  \<0.8                  24    0.55        0.496       1.643    (0.902--2.994)  0.105                                                11  0.64   0.971    2.642    (1.128--6.189)   0.025[a](#jpen1663-tbl3-note-0002){ref-type="fn"}
  0.8--1.2              116    1.03        −0.438      0.646    (0.418--0.996)  0.048[a](#jpen1663-tbl3-note-0002){ref-type="fn"}    45  1.03   0.461    1.585    (0.865--2.905)   0.136
  \>1.2                 157    1.44        Reference   70            1.42       Reference                                                                                          

β, beta coefficient; CI, confidence interval; HR, hazard ratio.

*P* \< 0.05 is considered statistically significant.

John Wiley & Sons, Ltd.

For non‐septic patients, early high protein intake was associated with significantly increased 6‐month mortality compared with low protein intake (HR: 3.902, 95% CI: 1.505‐10.115, *P* = 0.005; Table [3](#jpen1663-tbl-0003){ref-type="table"}, Figure S2). Conversely, in the later phase, low protein intake was associated with higher 6‐month mortality in univariate analysis compared with high protein intake (HR: 2.642, 95% CI: 1.128‐6.189, *P* = 0.025).

Subsequently, protein intakes during days 1--3 and 4--7 were combined, and different feeding regimens were evaluated (Table [4](#jpen1663-tbl-0004){ref-type="table"}). Four groups were assessed: patients who received \<0.8 g/kg/d the whole week (group 1), \<0.8 on days 1--3 and \>0.8 g/kg/d on days 4--7 (group 2), 0.8--1.2 g/kg/d the whole week (group 3), and \>1.2 g/kg/d the whole week (group 4). In septic patients, group 3 was significantly associated with a better survival in univariate analysis (HR: 0.315, 95% CI: 0.124‐0.798, *P* = 0.015) compared with an overall low protein intake. In non‐septic patients, group 2 showed a trend toward better survival (HR: 0.414, 95% CI: 0.162‐1.056, *P* = 0.065) compared with an overall low protein intake.

###### 

Univariate Cox Proportional Hazards Model 6‐Month Mortality: Proteins‐Combined Early and Later Phase

  Protein Intake      Sepsis  No Sepsis                                                                                                                                           
  ------------------ -------- ----------- ----------- ------- ---------------- --------------------------------------------------- ----- ------ -------- ------- ---------------- -------
  \<0.8 overall         19    0.44        Reference   8             0.49       Reference                                                                                          
  \<0.8 to \>0.8       215    0.93        −0.524      0.592    (0.306--1.146)  0.120                                                102  0.93   −0.882   0.414    (0.162--1.056)  0.065
  0.8--1.2 overall      39    0.95        −1.156      0.315    (0.124--0.798)  0.015[a](#jpen1663-tbl4-note-0002){ref-type="fn"}    11   0.97   −0.798   0.450    (0.121--1.679)  0.235
  \>1.2 overall         24    1.34        −0.170      0.844    (0.358--1.987)  0.697                                                 5   1.18   0.423    1.527    (0.409--5.706)  0.529

β, beta coefficient; CI, confidence interval; HR, hazard ratio.

*P* \< 0.05 is considered statistically significant.

John Wiley & Sons, Ltd.

Secondary endpoints were evaluated for the different protein feeding regimens (Table [5](#jpen1663-tbl-0005){ref-type="table"}). In septic patients, overall protein intake of 0.8--1.2 g/kg/d was associated with decreased ventilation duration, ICU, in‐hospital, 28‐day mortality, and 6‐month readmission rates. However, ICU LOS was significantly lower in the low to high (\<0.8 to \>0.8) intake group, all compared with an overall low protein intake. Other secondary end points were not significantly associated with protein intake (Table [5](#jpen1663-tbl-0005){ref-type="table"}).

###### 

Outcome Measures to Protein Intake Group with Combined Early and Later Phase Feeding Regimen

                                                                                                                                                          Sepsis                                                                              No Sepsis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  --------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------- -------------------------------------------------------------------------------------------------------- -------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------- --------------------------------------------------------- ------------------ ----------------------------------------------------- -----------------------------------------------------------------------------------------------------
  Mortality                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  ICU mortality, n of events/n total (%)                                                                                          7/19 (37)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                      39/215 (18)                                                   3/39 (8)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                  6/24 (25)                                                   0.010[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                    5/8 (63)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                            13/102 (13)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}      3/11 (27)                            2/5 (40)                                                  0.003[b](#jpen1663-tbl5-note-0003){ref-type="fn"}
  In‐hospital mortality, n of events/n total (%)                                                                                  9/19 (47)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                      55/215 (26)                                                  7/39 (18)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                  8/24 (33)                                                   0.029[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                    5/8 (63)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                            26/102 (26)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}      3/11 (27)                            3/5 (60)                                                  0.039[b](#jpen1663-tbl5-note-0003){ref-type="fn"}
  28‐day mortality, n of events/n total (%)                                                                                       7/19 (37)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                      48/215 (22)                                                  4/39 (10)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                  7/24 (29)                                                   0.029[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                                          3/8 (38)                                                                        20/102 (21)                            3/11 (27)                            3/5 (60)                                                                        0.133
  6‐month mortality, n of events/n total (%)                                                                                      10/19 (53)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                     75/215 (35)                          8/39 (21)[b](#jpen1663-tbl5-note-0003){ref-type="fn"} ^,^ [c](#jpen1663-tbl5-note-0004){ref-type="fn"}   11/24 (46)[c](#jpen1663-tbl5-note-0004){ref-type="fn"}   0.018[b](#jpen1663-tbl5-note-0003){ref-type="fn"} 0.048[c](#jpen1663-tbl5-note-0004){ref-type="fn"}                                                 5/8 (63)                                                                        36/102 (35)                            4/11 (36)                            4/5 (80)                                                                        0.111
  LOS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  ICU LOS days, median \[IQR\]                                                                                                 22 \[14--30.5\][b](#jpen1663-tbl5-note-0003){ref-type="fn"}                            16 \[11--25\][b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                             14 \[11.5--26.5\]                                                                 13 \[11--28.5\]                                                0.038[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                                     24.5 \[7.5--52.5\]                                                                 14.5 \[11--24\]                        13 \[10--19\]                        13 \[12--13\]                                                                     0.635
  Hospital LOS days, median \[IQR\]                                                                                                                  27 \[19.5--43\]                                                                       29 \[18.5--42\]                                                                   28 \[21--41.5\]                                                                25.5 \[14.5--36.5\]                                                                    0.613                                                                                            37.5 \[10.5--57\]                                                                 26.5 \[19--44\]                       23 \[18.5--53\]                       26 \[15--31\]                                                                     0.913
  Organ failure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Ventilation duration days, median \[IQR\]                                                            15 \[11--24.5\][b](#jpen1663-tbl5-note-0003){ref-type="fn"} ^,^ [c](#jpen1663-tbl5-note-0004){ref-type="fn"}   11 \[8--17\][b](#jpen1663-tbl5-note-0003){ref-type="fn"}                           10 \[8--15\][c](#jpen1663-tbl5-note-0004){ref-type="fn"}                                             10.5 \[8--19.5\]                      0.031[b](#jpen1663-tbl5-note-0003){ref-type="fn"} 0.013[c](#jpen1663-tbl5-note-0004){ref-type="fn"}                                             19 \[7.5--35.5\]                                                                   10 \[8--14\]                         10 \[8.5--12.5\]                      10 \[8--11\]                                                                      0.776
  Presence of AKI[d](#jpen1663-tbl5-note-0005){ref-type="fn"} n of events/n total (%)                                                                    1/19 (5)                                                                            13/215 (6)                                                                         4/39 (10)                                                                         1/24 (4)                                                                         0.740                                                                                                 0/8 (0)                                                                        15/102 (15)                             0/11 (0)                             0/5 (0)                                                                        0.261
  Need for CRRT, n of events/n total (%)                                                                                                                6/19 (32)                                                                            57/215 (27)                                                                        6/39 (15)                                                                         2/24 (8)                                                                         0.103                                                  6/8 (75)[b](#jpen1663-tbl5-note-0003){ref-type="fn"} ^,^ [c](#jpen1663-tbl5-note-0004){ref-type="fn"}   26/102 (26)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}      4/11 (36)       0/5 (0)[c](#jpen1663-tbl5-note-0004){ref-type="fn"}   0.007[b](#jpen1663-tbl5-note-0003){ref-type="fn"} 0.021[c](#jpen1663-tbl5-note-0004){ref-type="fn"}
  Number of days on CRRT, median \[IQR\]                                                                                                               10 \[9--16\]                                                                          7 \[4--10\]                                                                       5 \[4--11\]                                                                     16.5 \[8--25\]                                                                      0.148                                                                                              14 \[6--28\]                                                                      7 \[5--12\]                          3.5 \[2--6.5\]                            NA                                                                           0.099
  Other                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  6‐Month hospital readmission[e](#jpen1663-tbl5-note-0006){ref-type="fn"}, n of events/n total (%)                               3/19 (16)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                      69/215 (32)                                                  17/39 (44)[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                 9/24 (38)                                                   0.044[b](#jpen1663-tbl5-note-0003){ref-type="fn"}                                                                          1/8 (13)                                                                        38/102 (37)                            3/11 (27)                            1/5 (20)                                                                        0.426

AKI, acute kidney injury; CRRT, continuous renal replacement therapy; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; NA, not applicable.

All groups were compared for sepsis and no sepsis separately using χ^2^ tests or Fischer exact tests where appropriate.

Statistical differences between the groups with corresponding *P*‐value.

Statistical differences between the groups with corresponding *P*‐value.

AKI, positive Rifle criteria for AKI, acute kidney failure or loss of renal function.

6‐Month all‐cause hospital readmission.

John Wiley & Sons, Ltd.

For non‐septic patients, ICU and in‐hospital mortality and need for Continuous Renal Replacement Therapy (CRRT) was lower in group 2 (\<0.8 to \>0.8 g/kg/d; Table [5](#jpen1663-tbl-0005){ref-type="table"}) compared with an overall low intake. Other secondary endpoints were not significantly different between the subgroups.

Subgroup Analysis: Energy {#jpen1663-sec-0210}
-------------------------

In septic patients, no significant associations were found between early energy intake and 6‐month mortality (Table [6](#jpen1663-tbl-0006){ref-type="table"}, Figure S4, Table S5). In the later phase, medium (80%--110%) and high energy intake (\>110%) were significantly better than low energy intake (\<80%) (HR: 0.583, 95% CI: 0.343‐0.991, *P* = 0.046 for medium energy intake; HR: 0.400, 95% CI: 0.222‐0.721, *P* = 0.002 for high energy intake; Table [6](#jpen1663-tbl-0006){ref-type="table"}, Figure S5).

###### 

Univariate Cox Proportional Hazards Model 6‐Month Mortality: Energy‐First Week Separated in Early and Later Phase

  Energy Intake          Sepsis   No Sepsis                                                                                                                                        
  --------------------- -------- ----------- ----------- ------- ---------------- --------------------------------------------------- ---- ----- -------- ------- ---------------- ---------------------------------------------------
  Days 1--3                                                                                                                                                                        
  \<80% of target         178        51      Reference   90             48        Reference                                                                                        
  80%--110% of target     102        91      0.176       1.192    (0.800--1.777)  0.387                                                28   89   0.094    1.099    (0.555--2.174)  0.787
  \>110% of target         17        130     −0.778      0.459    (0.144--1.464)  0.188                                                8    120  0.676    1.967    (0.767--5.041)  0.159
  Days 4--7                                                                                                                                                                        
  \<80% of target          34        65      Reference   15             69        Reference                                                                                        
  80%--110% of target     158        100     −0.539      0.583    (0.343--0.991)  0.046[a](#jpen1663-tbl6-note-0002){ref-type="fn"}    75   100  −0.971   0.379    (0.175--0.820)  0.014[a](#jpen1663-tbl6-note-0002){ref-type="fn"}
  \>110% of target        105        130     −0.916      0.400    (0.222--0.721)  0.002[a](#jpen1663-tbl6-note-0002){ref-type="fn"}    36   139  −0.422   0.655    (0.292--1.471)  0.306

β, beta‐coefficient; CI, confidence interval; HR, hazard ratio.

*P*‐value \< 0.05 is considered statistically significant.

John Wiley & Sons, Ltd.

In non‐septic patients also, no significant associations for early energy intake were found. An energy intake of 80%--110% at days 4--7 was associated with a significantly lower 6‐month mortality compared with low energy intake (HR: 0.379, 95% CI: 0.175‐0.820, *P* = 0.014; Table [6](#jpen1663-tbl-0006){ref-type="table"}, Figure S4, Figure S5).

Associations between macronutrient intake and 6‐month mortality were not significantly influenced by any admission year. In case significance was lost in leave‐1‐out cross‐validation, direction of the observed associations (ie, β) did not change.

Discussion {#jpen1663-sec-0220}
==========

We found divergent associations of protein and energy intake and 6‐month mortality during the first week of ICU admission among critically ill adult patients with sepsis compared with those without sepsis.

Septic Patients {#jpen1663-sec-0230}
---------------

A late protein intake of 0.8--1.2 g/kg/d was associated with the lowest 6‐month mortality. No strong time‐dependent effects were observed. A secondary analysis of an observational study in 2270 septic patients reported a decrease in 60‐day mortality when increasing protein intake by 30 g/d (odds ratio: 0.76, *P* \< 0.001) from 0.7 g/kg/d.[11](#jpen1663-bib-0011){ref-type="ref"} These results could be in line with our findings; however, no time‐dependent effects were taken into account. Contradictory findings with a significantly decreased mortality due to high protein intake (1.5 vs 1.1 vs 0.8 g/kg/d) in sepsis were reported by Allingstrup et al.[12](#jpen1663-bib-0012){ref-type="ref"} In addition, Weijs et al reported no significant association of hospital mortality with protein intake at day 4 in sepsis.[17](#jpen1663-bib-0017){ref-type="ref"}

In our study, overfeeding, defined as an intake above 110% of the calculated energy target, was associated with better long‐term survival in septic patients; however, this is known to be harmful in general critically ill patients.[26](#jpen1663-bib-0026){ref-type="ref"} Partially in line with our findings, Weijs et al reported no harmful effects nor beneficial effects from energy overfeeding in septic patients.[17](#jpen1663-bib-0017){ref-type="ref"}

Because of contradictory findings of different studies, large prospective studies in septic patients are warranted to develop proper clinical guidelines in this large subgroup of critically ill patients.

Non‐Sepsis Patients {#jpen1663-sec-0240}
-------------------

A strong time‐dependent effect of protein intake was observed. Early high protein intake was associated with higher 6‐month mortality, whereas late high protein intake showed a trend toward lower mortality. These findings are concordant with those of Casaer et al[40](#jpen1663-bib-0040){ref-type="ref"} and Weijs et al,[17](#jpen1663-bib-0017){ref-type="ref"} who found an association with harm on day 3[40](#jpen1663-bib-0040){ref-type="ref"} but either no effect[40](#jpen1663-bib-0040){ref-type="ref"} or a beneficial effect of high protein intake ≥day 4.[17](#jpen1663-bib-0017){ref-type="ref"} Contradictory, Ferrie et al did not find an effect of early protein intake on mortality, comparing patients receiving parenteral nutrition at doses of 0.87 vs 1.17 g/kg/d (days 1--3).[13](#jpen1663-bib-0013){ref-type="ref"} However, the differences in protein intake between these groups were relatively small, and both groups would relate to our medium protein intake category (0.8--1.2 g/kg/d).

As reported in multiple studies, we also found energy overfeeding to be associated with higher mortality in non‐sepsis patients.[14](#jpen1663-bib-0014){ref-type="ref"}, [17](#jpen1663-bib-0017){ref-type="ref"}, [27](#jpen1663-bib-0027){ref-type="ref"} Furthermore, we did not find a survival benefit for early medium (80%--110%) energy intake compared with early low energy intake, in line with recent RCTs.[24](#jpen1663-bib-0024){ref-type="ref"}, [25](#jpen1663-bib-0025){ref-type="ref"}

Based on our findings and those in other recent studies, we suggest to prospectively investigate build‐up regimens in protein intake (0.8 g/kg/d in days 1--3 followed by \>1.2 g/kg/d from day 4) and energy intake at 70%--90% of target in non‐sepsis patients.[17](#jpen1663-bib-0017){ref-type="ref"}, [32](#jpen1663-bib-0032){ref-type="ref"}

Pathophysiology {#jpen1663-sec-0250}
---------------

We hypothesized that early high protein intake would be more harmful to septic patients because early high protein intake is supposed to inhibit autophagy.[20](#jpen1663-bib-0020){ref-type="ref"} However, we did not observe these associations in septic patients, contrary to non‐septic patients. These observations may indicate a difference between these 2 groups and underline the importance for prospective research within both groups to address this hypothesis. Our study was not designed to address the association between autophagy, sepsis, and protein intake, and conclusions regarding these associations therefore cannot be drawn.

In addition to prospective research, further basic research is warranted to obtain more insight in the process of autophagy. It is possible, and we speculate, that patients with sepsis have different or earlier activation of autophagy.[41](#jpen1663-bib-0041){ref-type="ref"}, [42](#jpen1663-bib-0042){ref-type="ref"} Furthermore, different levels of catabolism and absorption rates of macronutrients from the gut also might play a role in any potential differences between septic and non‐septic patients.[43](#jpen1663-bib-0043){ref-type="ref"}

Strengths and Weaknesses {#jpen1663-sec-0260}
------------------------

Strict adherence to our feeding protocol (mean start of feeding 6 hours after admission) facilitated early evaluation and analysis of possible time‐dependent effects of nutrition support. The number of (sepsis) patients included, covariates taken into account, inclusion of non‐nutrition energy, and the long follow‐up period (6 months) are other strengths.

Limitations of our study and its single‐center retrospective design include potential selection of the sicker ICU patients due to including only prolonged mechanically ventilated patients. This may potentially lead to selection bias and residual confounding, limiting external validity. In addition, some subgroups in our analyses were very small, and energy targets were based on the FAO/WHO formulas and not on indirect calorimetry. Generalization of our study should be done with caution, and we strongly emphasize that large adequately powered RCTs are warranted to address causality of the observed associations.

Conclusions {#jpen1663-sec-0270}
===========

We found divergent associations of protein and energy intake during the first week of ICU admission among critically ill adult patients with sepsis compared with those without sepsis. In septic patients, we observed that late medium protein and late high energy intake were associated with survival benefit. For non‐septic patients, a strong time‐dependent effect was observed; early high protein intake was associated with higher 6‐month mortality, whereas in the later phase an intake of \>0.8 g/kg/d might be beneficial.
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**Figure S1**. Flowchart of enrolled patients. ICU, intensive care unit; SOFA, Sequential Organ Failure Assessment.
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**Figure S2**. Kaplan‐Meier 6‐month survival curves for protein intake subgroups days 1--3, sepsis and no sepsis. ICU, intensive care unit.
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**Figure S3**. Kaplan‐Meier 6‐month survival curves for protein intake subgroups days 4--7, sepsis and no sepsis. ICU, intensive care unit.

###### 

Click here for additional data file.

###### 

**Figure S4**. Kaplan‐Meier 6‐month survival curves for caloric intake subgroups days 1--3, sepsis and no sepsis. ICU, intensive care unit.
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**Figure S5**. Kaplan‐Meier 6‐month survival curves for caloric intake subgroups days 4--7, sepsis and no sepsis. ICU, intensive care unit.
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**Table S1**. Multivariate Cox Proportional‐Hazard Model 6‐Month Mortality: Proteins---Separated Early and Later Phase.
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**Table S2**. Multivariate Cox Proportional‐Hazards Model 6‐Months Mortality: Proteins---Combined Early and Later Phase
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**Table S3**. Multivariate Cox Proportional‐Hazards Model 6‐Month Mortality: Calories---Separated Early and Later Phase.
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**Table S4**. Univariate Cox Proportional‐Hazards Model 6‐Month Mortality: Proteins---Separated Early and Later Phase, Continuous Data.
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**Table S5**. Univariate Cox Proportional‐Hazards Model 6‐Month Mortality: Calories---Separated Early and Later Phase, Continuous Data.
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